Baird Medical Expands U.S. Footprint with First Benign Thyroid Tumor Ablation at Bakersfield Memorial
Event summary
- Baird Medical launched its Microwave Ablation (MWA) technology at Bakersfield Memorial Hospital on February 11, 2026, marking the first ablation case for benign thyroid tumors in the San Joaquin Valley.
- The procedure was performed by Dr. Tim Beck, a distinguished Endocrine Surgeon at Dignity Health Medical Group, demonstrating the system's high-efficiency ablation capabilities and favorable safety profile.
- Baird Medical's technology has been used in over 30 prestigious hospitals and clinics across the United States, including Mayo Clinic and Columbia University Medical Center.
- The company is also the market leader in China in thyroid microwave ablation devices and consumables, with its products expanding commercially in over 20 countries worldwide.
The big picture
Baird Medical's strategic deployment at Bakersfield Memorial Hospital underscores its commitment to expanding access to minimally invasive technologies in key U.S. markets. The company's focus on high-efficiency ablation capabilities aligns with broader industry trends toward precision medicine and minimally invasive surgical solutions. With a strong foothold in China and growing international presence, Baird Medical is positioning itself as a global leader in advanced diagnostic and treatment technologies.
What we're watching
- Market Penetration
- How Baird Medical will leverage this launch to accelerate adoption in other U.S. regional markets.
- Technological Validation
- Whether the successful procedure at Bakersfield Memorial will drive further validation and adoption in high-volume hospital settings.
- Global Expansion
- The pace at which Baird Medical can expand its commercial presence beyond the U.S. and China.
Related topics